nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Distinct Region in Erythropoietin that Induces Immuno/Inflammatory Modulation and Tissue Protection
|
Yuan, RuiRong |
|
2015 |
12 |
4 |
p. 850-861 |
artikel |
2 |
A Distinct Region in Erythropoietin that Induces Immuno/Inflammatory Modulation and Tissue Protection
|
Yuan, RuiRong |
|
|
12 |
4 |
p. 850-861 |
artikel |
3 |
An Overview of Products and Bias in Research
|
Gloss, David |
|
2015 |
12 |
4 |
p. 731-734 |
artikel |
4 |
An Overview of Products and Bias in Research
|
Gloss, David |
|
|
12 |
4 |
p. 731-734 |
artikel |
5 |
Cannabidiol as a Potential Treatment for Anxiety Disorders
|
Blessing, Esther M. |
|
2015 |
12 |
4 |
p. 825-836 |
artikel |
6 |
Cannabidiol as a Potential Treatment for Anxiety Disorders
|
Blessing, Esther M. |
|
|
12 |
4 |
p. 825-836 |
artikel |
7 |
Cannabinoids and Epilepsy
|
Rosenberg, Evan C. |
|
2015 |
12 |
4 |
p. 747-768 |
artikel |
8 |
Cannabinoids and Epilepsy
|
Rosenberg, Evan C. |
|
|
12 |
4 |
p. 747-768 |
artikel |
9 |
Cannabinoids and Schizophrenia: Risks and Therapeutic Potential
|
Manseau, Marc W. |
|
2015 |
12 |
4 |
p. 816-824 |
artikel |
10 |
Cannabinoids and Schizophrenia: Risks and Therapeutic Potential
|
Manseau, Marc W. |
|
|
12 |
4 |
p. 816-824 |
artikel |
11 |
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?
|
Arjmand, Shokouh |
|
2015 |
12 |
4 |
p. 778-787 |
artikel |
12 |
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?
|
Arjmand, Shokouh |
|
|
12 |
4 |
p. 778-787 |
artikel |
13 |
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
|
Fernández-Ruiz, Javier |
|
2015 |
12 |
4 |
p. 793-806 |
artikel |
14 |
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
|
Fernández-Ruiz, Javier |
|
|
12 |
4 |
p. 793-806 |
artikel |
15 |
Cannabinoids in the Treatment of Neurological Disorders
|
Devinsky, Orrin |
|
2015 |
12 |
4 |
p. 689-691 |
artikel |
16 |
Cannabinoids in the Treatment of Neurological Disorders
|
Devinsky, Orrin |
|
|
12 |
4 |
p. 689-691 |
artikel |
17 |
Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics
|
Koppel, Barbara S. |
|
2015 |
12 |
4 |
p. 788-792 |
artikel |
18 |
Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics
|
Koppel, Barbara S. |
|
|
12 |
4 |
p. 788-792 |
artikel |
19 |
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis
|
Notcutt, William G. |
|
2015 |
12 |
4 |
p. 769-777 |
artikel |
20 |
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis
|
Notcutt, William G. |
|
|
12 |
4 |
p. 769-777 |
artikel |
21 |
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage
|
Hurd, Yasmin L. |
|
2015 |
12 |
4 |
p. 807-815 |
artikel |
22 |
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage
|
Hurd, Yasmin L. |
|
|
12 |
4 |
p. 807-815 |
artikel |
23 |
Effect of Readthrough Treatment in Fibroblasts of Patients Affected by Lysosomal Diseases Caused by Premature Termination Codons
|
Matalonga, Leslie |
|
2015 |
12 |
4 |
p. 874-886 |
artikel |
24 |
Effect of Readthrough Treatment in Fibroblasts of Patients Affected by Lysosomal Diseases Caused by Premature Termination Codons
|
Matalonga, Leslie |
|
|
12 |
4 |
p. 874-886 |
artikel |
25 |
Endocannabinoid Signaling in Autism
|
Chakrabarti, Bhismadev |
|
2015 |
12 |
4 |
p. 837-847 |
artikel |
26 |
Endocannabinoid Signaling in Autism
|
Chakrabarti, Bhismadev |
|
|
12 |
4 |
p. 837-847 |
artikel |
27 |
Enduring Elevations of Hippocampal Amyloid Precursor Protein and Iron Are Features of β-Amyloid Toxicity and Are Mediated by Tau
|
Li, Xuling |
|
2015 |
12 |
4 |
p. 862-873 |
artikel |
28 |
Enduring Elevations of Hippocampal Amyloid Precursor Protein and Iron Are Features of β-Amyloid Toxicity and Are Mediated by Tau
|
Li, Xuling |
|
|
12 |
4 |
p. 862-873 |
artikel |
29 |
Erratum to: Cannabinoids in the Treatment of Neurological Disorders
|
Devinsky, Orrin |
|
2015 |
12 |
4 |
p. 910 |
artikel |
30 |
Erratum to: Cannabinoids in the Treatment of Neurological Disorders
|
Devinsky, Orrin |
|
|
12 |
4 |
p. 910 |
artikel |
31 |
Erratum to: Parsing Physiological Functions of Erythropoietin One Domain at a Time
|
Steinman, Lawrence |
|
2015 |
12 |
4 |
p. 911 |
artikel |
32 |
Erratum to: Parsing Physiological Functions of Erythropoietin One Domain at a Time
|
Steinman, Lawrence |
|
|
12 |
4 |
p. 911 |
artikel |
33 |
Molecular Targets of Cannabidiol in Neurological Disorders
|
Ibeas Bih, Clementino |
|
2015 |
12 |
4 |
p. 699-730 |
artikel |
34 |
Molecular Targets of Cannabidiol in Neurological Disorders
|
Ibeas Bih, Clementino |
|
|
12 |
4 |
p. 699-730 |
artikel |
35 |
Neuroinflammation: Ways in Which the Immune System Affects the Brain
|
Ransohoff, Richard M. |
|
2015 |
12 |
4 |
p. 896-909 |
artikel |
36 |
Neuroinflammation: Ways in Which the Immune System Affects the Brain
|
Ransohoff, Richard M. |
|
|
12 |
4 |
p. 896-909 |
artikel |
37 |
Parsing Physiological Functions of Erythropoietin One Domain at a Time
|
Steinman, Lawrence |
|
2015 |
12 |
4 |
p. 848-849 |
artikel |
38 |
Parsing Physiological Functions of Erythropoietin One Domain at a Time
|
Steinman, Lawrence |
|
|
12 |
4 |
p. 848-849 |
artikel |
39 |
Safety and Toxicology of Cannabinoids
|
Sachs, Jane |
|
2015 |
12 |
4 |
p. 735-746 |
artikel |
40 |
Safety and Toxicology of Cannabinoids
|
Sachs, Jane |
|
|
12 |
4 |
p. 735-746 |
artikel |
41 |
The Endocannabinoid System and its Modulation by Phytocannabinoids
|
Di Marzo, Vincenzo |
|
2015 |
12 |
4 |
p. 692-698 |
artikel |
42 |
The Endocannabinoid System and its Modulation by Phytocannabinoids
|
Di Marzo, Vincenzo |
|
|
12 |
4 |
p. 692-698 |
artikel |
43 |
Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
|
Boostani, Reza |
|
2015 |
12 |
4 |
p. 887-895 |
artikel |
44 |
Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
|
Boostani, Reza |
|
|
12 |
4 |
p. 887-895 |
artikel |